戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 c associated cerebral oedema and neuroleptic malignant syndrome.
2 gans that function abnormally in neuroleptic malignant syndrome.
3 hotics and resembles "classical" neuroleptic malignant syndrome.
4 high or low probability of being neuroleptic malignant syndrome.
5 having high probability of being neuroleptic malignant syndrome.
6 elated to (but misattributed as) neuroleptic malignant syndrome.
7 or most, if not all, features of neuroleptic malignant syndrome.
8 roduces the clinical syndrome of neuroleptic malignant syndrome.
9  13 cases of risperidone-induced neuroleptic malignant syndrome against three criteria sets and again
10 ed 19 cases of clozapine-induced neuroleptic malignant syndrome and 13 cases of risperidone-induced n
11 he 19 cases of clozapine-related neuroleptic malignant syndrome and eight of the 13 cases of risperid
12 scussed: malignant hyperthermia, neuroleptic malignant syndrome, anticholinergic poisoning, sympathom
13                                  Neuroleptic malignant syndrome can occur in patients given atypical
14 ofiles overlap considerably with neuroleptic malignant syndrome criteria, and atypical antipsychotics
15 was to analyze reported cases of neuroleptic malignant syndrome in patients given clozapine and rispe
16 treatment of serotonin syndrome, neuroleptic malignant syndrome, malignant hyperthermia, and baclofen
17 nd costly contemporary medical problems, the malignant syndrome of advanced heart failure.
18 acute urinary retention, and the neuroleptic malignant syndrome or rhabdomyolysis.
19                                  Neuroleptic malignant syndrome should be treated by discontinuing do
20  13 cases of risperidone-related neuroleptic malignant syndrome were designated as having high probab
21   Published clinical findings on neuroleptic malignant syndrome were integrated with data from human
22 titute a trait vulnerability for neuroleptic malignant syndrome, which, when coupled with state varia
23 p a pathophysiological model for neuroleptic malignant syndrome with greater explanatory power than t
24 t evidence exists for "atypical" neuroleptic malignant syndrome with novel antipsychotics.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。